We recently published a list of 10 Best Weight Loss Drug Stocks to Buy According to Analysts. In this article, we are going ...

Glaxo (GSK) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

The court directed the firm to pay Ms Gichuki 10 months’ salary as compensation would be adequate in the circumstances ...

The British pharma giant said Emma Walmsley's current pay could put off candidates for her eventual successor.

Furthermore, GSK is well known for providing its brand products with a price in Egypt that can be a fraction of its regular price in the region. Of the top 20 multinational corporations working in ...

Despite early success, Verona's lack of specific 2025 guidance and competition from Dupixent and other drugs raise concerns.

GSK's revenue and EPS exceeded my expectations ... part of the dolutegravir products in the chart below. Let's dive into the reasons for Dovato's sales growth, which totaled $813 million, up ...

GSK has historically been strong in vaccines ... said investors were confident about the company’s ability to commercialise products, but saw its research and development as more of a “work ...

The first would be products innovated in China and brought ... Formerly known as GlaxoSmithKline, GSK plc (NYSE:GSK) is a global healthcare and pharmaceutical corporation that develops and ...

The four-pronged strategy begins with the acquisition of GSK's oncology portfolio, which includes all of its marketed products and late-stage candidates, for $14.5 billion, with a further $1.5 ...